A. Van Vreckem
- Oncology top 5%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Dermatology top 5%
- Molecular Biology
- Co-authors
- Martine PiccartRobert ParidaensRichard SylvesterAhmad AwadaRobert E. ColemanP.F. BruningStephen HoustonTeresa Gamucci
- Topics
- Cancer Treatment and Pharmacology (9 papers)Breast Cancer Treatment Studies (5 papers)Estrogen and related hormone effects (4 papers)
- Cited by
- OncologyCancer ResearchDermatology
- Partner nations
- BelgiumNetherlandsUnited Kingdom
In The Last Decade
A. Van Vreckem
14 papers receiving 569 citations
Peers
Comparison fields: 5 of 86
- Oncology 459
- Cancer Research 216
- Pulmonary and Respiratory Medicine 98
- Dermatology 76
- Molecular Biology 72
Countries citing papers authored by A. Van Vreckem
This map shows the geographic impact of A. Van Vreckem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Van Vreckem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Van Vreckem more than expected).
Fields of papers citing papers by A. Van Vreckem
This network shows the impact of papers produced by A. Van Vreckem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Van Vreckem. The network helps show where A. Van Vreckem may publish in the future.
Co-authorship network of co-authors of A. Van Vreckem
This figure shows the co-authorship network connecting the top 25 collaborators of A. Van Vreckem. A scholar is included among the top collaborators of A. Van Vreckem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Van Vreckem. A. Van Vreckem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 82 | |
| 2 | 4 | |
| 3 | 3 | |
| 4 | 288 | |
| 5 | 42 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 126 | |
| 9 | 2 | |
| 10 | 6 | |
| 11 | 3 | |
| 12 | 1 | |
| 13 | An ongoing European organization for research and treatment of cancer crossover trial comparing single-agent paclitaxel and doxorubicin as first- and second-line treatment of advanced breast cancer. | 12 |
| 14 | 11 | |
| 15 | 0 | |
| 16 | Study of excretion balance, metabolism and protein binding of Caradiolabelled Taxotere (TXT) (RP56976, NSC628503) in cancer patients. | 11 |
About A. Van Vreckem
A. Van Vreckem is a scholar working on Oncology, Cancer Research and Toxicology, having authored 16 papers that have together received 597 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (5 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Oncology (459 citations), Cancer Research (216 citations) and Dermatology (76 citations). A. Van Vreckem has collaborated with scholars based in Belgium, Netherlands and United Kingdom. Frequent co-authors include Martine Piccart, Robert Paridaens, Richard Sylvester, Ahmad Awada, Robert E. Coleman, P.F. Bruning, Stephen Houston, Teresa Gamucci, J.G.M. Klijn and Laura Biganzoli. Their work appears in journals such as Journal of Clinical Oncology, Statistics in Medicine and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.